Showing results (451-460 of 730) with videos related to

Sort By:
Pageof 73
Circulation. Cardiovascular Quality and Outcomes|June 14, 2013
End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experienceKenneth W Mahaffey, Anne S Hellkamp, Manesh R Patel, et al.
European Heart Journal|September 12, 2014
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF TrialBenjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Journal of the American Heart Association|March 10, 2016
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AFSean D Pokorney, Jonathan P Piccini, Susanna R Stevens, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational studyRoss I Baker, Grace Gilmore, Vivien Chen, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 25, 2021
Secondary Prevention of Stroke: Study Protocol for a Telehealth-Delivered Physical Activity and Diet Pilot Randomized Trial (ENAbLE-Pilot)Coralie English, John R Attia, Julie Bernhardt, et al.
AIDS (London, England)|December 13, 2001
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort studyGail V Matthews, Caroline A Sabin, Sundhiya Mandalia, et al.
Pageof 73